Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells-Reference-Cited by-同舟云学术

Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells

Published:2012-07-19 Issue:11 Volume:227 Page:3621-3628
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Lupu-Meiri Monica,Geras-Raaka Elizabeth,Lupu Ruth,Shapira Hagit,Sandbank Judith,Segal Liora,Gershengorn Marvin C.,Oron Yoram

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference29 articles.

1. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization;Bajou;Nat Med,1998

2. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth;Bajou;Oncogene,2004

3. A deficiency of uPAR alters endothelial angiogenic function and cell morphology;Balsara;Vasc Cell,2011

4. The plasminogen activator inhibitor “paradox” in cancer;Binder;Immunol Lett,2008

5. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity;Czekay;Mol Biol Cell,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors;Cancer Letters;2023-04

2. Combined Alcohol Exposure and KRAS Mutation in Human Pancreatic Ductal Epithelial Cells Induces Proliferation and Alters Subtype Signatures Determined by Multi-Omics Analysis;Cancers;2022-04-13

3. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer;Blood Advances;2021-01-21

4. Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival;Journal for ImmunoTherapy of Cancer;2021-01

5. Engineering of biomaterials for tumor modeling;Materials Today Advances;2020-12